The soluble isoform inhibitor of the RAGE receptor Torin 1 (sRAGE) was also used to confirm the result. As was shown, cleaved caspase-1 was significantly inhibited after blocking RAGE with sRAGE treatment (Fig. 5D). To further confirm that both TLR4 and RAGE receptors are involved in hypoxia-induced caspase-1 activation, Hepa1-6 cells were simultaneously treated with anti-TLR4 neutralizing antibody and sRAGE. Cleaved caspase-1 was almost completely inhibited by blocking both TLR4 and RAGE (Fig. 5E). These results suggest that hypoxia-induced caspase-1 activation occurs through both TLR4- and RAGE-signaling

pathways. To date, four cytoplasmic receptors have been described that form an inflammasome complex: NOD-like receptor family, pyrin domain-containing protein (NLRP)1, NLRP3, IPAF, and absent in melanoma 2 (AIM2).14

To investigate which one is involved in hypoxia-induced caspase-1 activation, Hepa1-6 cells were transfected with NLRP1 siRNA, NLRP3 siRNA, IPAF siRNA, and AIM2 siRNA. All receptors were efficiently silenced by their respective siRNA (data not shown), but only NLRP3 siRNA was found to inhibit hypoxia-induced caspase-1 activation (Fig. 6A; Supporting Fig. 4C,D). These results suggest that hypoxia-induced caspase-1 activation in HCC cells is NLRP3 dependent. Next, we investigated signaling pathways downstream of caspase-1. The cytokines, IL-1β and -18, begin as cytosolic precursors that require cleavage by the cysteine protease, caspase-1, to generate biologically active molecules. Cleaved caspase-1, IL-1β, and IL-18 learn more were all increased after hypoxia (Fig. 6B-D). In contrast, all three were decreased after treatment with the caspase-1 inhibitor, Z-YVAD-FMK (carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]-fluoromethylketone) (Fig. 6B-D). As downstream effectors of caspase-1, both cytokines released from cancer cells can induce the production and secretion of other cytokines and chemokines, recruit stromal cells, and induce angiogenesis,

leading to tumor progression.15, 16 We next sought to determine the Florfenicol effects of hypoxia on HCC cell migration and invasion. Under hypoxia, Hepa1-6 cell migration was increased 2.04- ± 0.14-fold (P < 0.01; n = 6) in 1% O2 (Fig. 7A. Similarly, invasion of Hepa1-6 cells through reconstituted three-dimensional Matrigel matrices was increased 1.72- ± 0.12-fold (P < 0.01; n = 6) in 1% O2. To elucidate whether HMGB1-induced caspase-1 activation was responsible for the increase in cell invasion observed in hypoxia, Hepa1-6 cells were treated with anti-HMGB1 neutralizing antibodies. Blockade of HMGB1 inhibited the increase in cell invasion observed during hypoxia (Fig. 7B,C). We also examined caspase-1 inhibition in hypoxia-induced invasion. Hepa1-6 cells treated with the caspase-1 inhibitor, Z-YVAD-FMK, also exhibited significantly decreased hypoxia-induced invasion (Fig. 7B,C).